Project code
|
Project Title
|
Commencement date
|
Value per week
|
Pre-requisite Units
|
Project Contact
|
| 1228 |
Analysis of neural tube closure in a novel knockout mouse model |
Flexible
|
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Stephen Jane Stephen.Jane@monash.edu |
| 1229 |
Analysis of GRHL3 induction by Inositol stereoisomers for skin cancer prevention |
Flexible
|
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Stephen Jane Stephen.Jane@monash.edu |
| 1230 |
What is the microRNA expression profile of human keratinocytes in response to UVB irradiation? |
Flexible
|
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Stephen Jane Stephen.Jane@monash.edu |
| 1231 |
Analysis of neural tube closure in a novel knockout mouse model |
Flexible
|
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Stephen Jane Stephen.Jane@monash.edu |
| 1232 |
Analysis of GRHL3 induction by Inositol stereoisomers for skin cancer prevention |
Flexible
|
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Stephen Jane Stephen.Jane@monash.edu |
| 1233 |
What is the microRNA expression profile of human keratinocytes in response to UVB irradiation? |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Stephen Jane Stephen.Jane@monash.edu |
| 1234 |
Elucidating adaptive immune mechanisms that contribute to poor allograft outcomes in lung transplantation |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Oanh Nguyen oanh.nguyen@monash.edu |
| 1235 |
How does IGFBP-6 inhibit tumour angiogenesis? |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Ping Fu ping.fu@monash.edu |
| 1236 |
What is the microRNA expression profile of human keratinocytes in response to UVB irradiation? |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Smitha Georgy smitha.georgy@monash.edu |
| 1237 |
Role of ezrin in diabetic kidney disease |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Anne McRobert Anne.McRobert@monash.edu |
| 1238 |
To identify the oncogenic and/or tumour suppressor microRNAs differentially regulated in human skin as a result of UVB exposure* |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Smitha Georgy smitha.georgy@monash.edu |
| 1239 |
Innovative approaches to reducing risk of chronic disease in people living with HIV |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Julian Elliott julian.elliott@monash.deu |
| 1240 |
Role of ezrin in diabetic kidney disease |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Anne McRobert Anne.McRobert@monash.edu |
| 1241 |
Haematopoietic and Leukemia Stem Cell Self-Renewal via Asymmetric Cell Division |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Stephen Ting stephen.ting@petermac.org |
| 1242 |
What is the role of thoracic high resolution computed tomographic scan changes in the diagnosis of invasive aspergillosis in high-risk haematology patients? |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Orla Morrissey
o.morrissey@alfred.org.au |
| 1243 |
What is the role of bronchoalveolar lavage fluid and serum Aspergillus galactomannan enzyme-linked immunosorbent and PCR assays in the diagnosis of invasive aspergillosis in high-risk haematology patients? |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Orla Morrissey
o.morrissey@alfred.org.au |
| 1244 |
How should we manage Mycobacterium abscessus infection in lung transplant recipients? |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Orla Morrissey
o.morrissey@alfred.org.au |
| 1245 |
The laboratory has a number of projects aimed at determining the relationship between microbial translocation and liver disease progression in HIV-HBV co-infected patients |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Sharon Lewin Sharon.lewin@monash.edu |
| 1246 |
To determine the activity of chemokine receptor and chemokine antagonists in inhibiting the establishment of latency in vitro |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Sharon Lewin Sharon.lewin@monash.edu |
| 1247 |
To understand how HIV latency can be eliminated from infected astrocytes using a class of drugs used to treat cancer, called histone deacetylase inhibitors (HDACi) |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Sharon Lewin Sharon.lewin@monash.edu |
| 1248 |
Symptomatic treatment of incoordination in mice transgenic for hereditary ataxias. |
Flexible |
$250 x 6-10 weeks ($1500-$2500 total) |
NA |
Elsdon Storey elsdon.storey@monash.edu |
